These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2126028)

  • 21. [Measles control in developing countries].
    Cutts FT; Dabis F
    Sante; 1994; 4(3):163-71. PubMed ID: 7921681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of the expanded programme on immunization in the Ivory Coast: a preliminary assessment.
    Shepard DS; Sanoh L; Coffi E
    Soc Sci Med; 1986; 22(3):369-77. PubMed ID: 3008344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
    Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
    BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
    Enders-Ruckle G
    Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of measles revaccination among school-entry-aged children.
    Watson JC; Pearson JA; Markowitz LE; Baughman AL; Erdman DD; Bellini WJ; Baron RC; Fleming DW
    Pediatrics; 1996 May; 97(5):613-8. PubMed ID: 8628596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
    Zilber N; Rannon L; Alter M; Kahana E
    Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area.
    Goldblum N; Gerichter CB; Tulchinsky TH; Melnick JL
    Bull World Health Organ; 1994; 72(5):783-96. PubMed ID: 7955030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Measles epidemic in a highly developed country: low mortality, high morbidity and extensive costs].
    Donas A; Marty-Nussbaumer A; Roost HP; Neuhaus TJ
    Klin Padiatr; 2014 Jan; 226(1):13-8. PubMed ID: 24435790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles control in Israel: a decade of the two-dose policy.
    Slater PE; Anis E; Leventhal A
    Public Health Rev; 1999; 27(1-3):235-41. PubMed ID: 10832486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The difficult quest for data on "vanishing" vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium).
    Beutels P; Van Damme P; Van Casteren V; Gay NJ; De Schrijver K; Meheus A
    Vaccine; 2002 Oct; 20(29-30):3551-9. PubMed ID: 12297401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis.
    Acharya A; Diaz-Ortega JL; Tambini G; de Quadros C; Arita I
    Vaccine; 2002 Sep; 20(27-28):3332-41. PubMed ID: 12213403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States.
    Lo NC; Hotez PJ
    JAMA Pediatr; 2017 Sep; 171(9):887-892. PubMed ID: 28738137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 1991 measles epidemic in Israel.
    Slater PE; Roitman M; Costin C
    Public Health Rev; 1992-1993; 20(1-2):41-51. PubMed ID: 1305976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
    Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of vaccination policies. The case of measles].
    Lafarge H; Levy E; Rey M
    Rev Epidemiol Sante Publique; 1985; 33(3):182-93. PubMed ID: 4081224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness evaluation of measles immunization strategies on a college campus.
    Shlian DM; Matchar D; Seymann GB
    Fam Pract Res J; 1991 Jun; 11(2):193-207. PubMed ID: 1905455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-dose measles vaccination schedules.
    Rosenthal SR; Clements CJ
    Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles: not just another viral exanthem.
    Duke T; Mgone CS
    Lancet; 2003 Mar; 361(9359):763-73. PubMed ID: 12620751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine].
    He HQ; Zhang B; Yan R; Li Q; Fu J; Tang XW; Zhou Y; Deng X; Xie SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1121-6. PubMed ID: 27539345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.